Zahra Shiravani
Overview
Explore the profile of Zahra Shiravani including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
45
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fattahi M, Sedaghat F, Haghshenas M, Ariafar A, Shiravani Z, Malekzadeh M, et al.
Caspian J Intern Med
. 2024 Oct;
15(4):636-643.
PMID: 39359453
Background: Bladder cancer is one of the most common cancers in the world and is associated with high treatment costs and mortality. The role of different enzymes and molecules in...
2.
Fattahi M, Momtahan M, Poostkar M, Shiravani Z, Erfani N, Haghshenas M, et al.
Turk J Obstet Gynecol
. 2024 Jun;
21(2):57-63.
PMID: 38853448
Objective: To assess the possible association of two single-nucleotide polymorphisms (SNPs), PD-1.3 (+7146G/A) and PD-1.5 (+7785C/T), with endometrial cancer (EC) susceptibility. In addition, the correlations between these SNPs and available...
3.
Haghshenas M, Shiravani Z, Samare-Najaf M, Khansalar S, Razavinasab S, Ghaderi A, et al.
Eur Cytokine Netw
. 2024 Mar;
34(4):63-69.
PMID: 38526176
Endometrial cancer (EC) is recognized as the second most common type of cancer among women. Interleukin-37 (IL-37) is a recently discovered member of the IL-1 cytokine family characterized by its...
4.
Shiravani Z, Mirshekari K, Larki M, Shafiee N, Haghshenas M, Ghaderi A, et al.
J Reprod Immunol
. 2024 Feb;
162:104217.
PMID: 38387251
Endometrial cancer (EC) constitutes more than half of all genital cancers in women, with an increasing incidence in different countries. Natural killer cells (NK cells) are kinds of innate immune...
5.
Najib F, Bahrami S, Shiravani Z, Alavi S
Clin Case Rep
. 2023 Oct;
11(10):e7977.
PMID: 37780932
Key Clinical Message: Choriocarcinoma of the fallopian tube is extremely rare and highly susceptible to early metastasis. Clinical manifestations of ectopic pregnancy and choriocarcinoma are the same, and all patients...
6.
Shiravani Z, Bahrami S, Najib F, Alavi S
Clin Case Rep
. 2023 Oct;
11(10):e7967.
PMID: 37780922
Key Clinical Message: To date, there have been disparate reports regarding borderline forms of Brenner tumors, while research on concomitant mucinous proliferation is even more irregular; however, it has been...
7.
Shiravani Z, Nazari Z, Yazdani F, Najib F, Akbarzadeh Jahromi M, Momtahan M, et al.
Indian J Surg Oncol
. 2023 Jun;
14(2):504-509.
PMID: 37324297
Cervical cancer is the most common health problem among global young women. Cervical intraepithelial neoplasia (CIN) is a pre-invasive stage of cervical cancer, the major cause of which is human...
8.
Ahmadloo N, Heidarpourfard M, Najib F, Shiravani Z, Omidvari S, Mosalaei A, et al.
Asian Pac J Cancer Prev
. 2023 Apr;
24(4):1321-1330.
PMID: 37116155
Background: The present study aimed at investigating the feasibility and safety of induction chemotherapy followed by definitive chemoradiation (dCRT) in patients with locally advanced cervical cancer. Materials And Methods: In...
9.
Lotfi F, Khodabandeh F, Jafari A, Rezaee M, Rahimi H, Shiravani Z, et al.
Expert Rev Pharmacoecon Outcomes Res
. 2023 Mar;
23(4):439-447.
PMID: 36876411
Background: Cervical cancer is one of the most common cancers in women, the cause of which is mostly human papilloma virus (HPV). The aim of this study was to determine...
10.
Vafaei H, Faraji S, Ahmadi M, Tabei S, Fereidoni S, Shiravani Z, et al.
Taiwan J Obstet Gynecol
. 2023 Jan;
62(1):71-76.
PMID: 36720555
Objective: Pregnancy is a unique challenge for the immune system. Any disturbance in the immune system in the first trimester could result in further pregnancy complications. In this regard, the...